Co-proxamol and suicide: Licence needs to be changed

BMJ

Volumn 327, Issue 7409, 2003, Pages 287-

  Bateman, D N ^a   Afshari, r ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAMINOPHEN PROPOXYPHENE COMBINATION; ACETAMINOPHEN-PROPOXYPHENE COMBINATION; ANALGESIC AGENT; DEXTROPROPOXYPHENE; PARACETAMOL;

DRUG COMBINATION; DRUG LEGISLATION; HUMAN; INTOXICATION; NOTE; SUICIDE;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; DRUG COMBINATIONS; HUMANS; LEGISLATION, DRUG; OVERDOSE; PROPOXYPHENE; SUICIDE;

EID: 0345771763     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.327.7409.287     Document Type: Letter

References (5)

1. Hawton K, Simkin S, Deeks J. Co-proxamol and suicide: a study of national mortality statistics and local non-fatal self poisonings. BMJ 2003; 326: 1006–8. (10 May.)
2. Nickander RC, Emmerson JL, Hynes MD, Steinberg MI, Sullivan HR. Pharmacologic and toxic effects in animals of dextropropoxyphene and its major metabolite norpropoxyphene: a review. Hum Toxicol 1984; 3(suppl):S13–S36.
3. Stork CM, Redd JT, Fine K, Hoffman RS. Propoxyphene-induced wide QRS complex dysrhythmia responsive to sodium bicarbonate-a case report. J Toxicol Clin Toxicol 1995; 33: 179–83.
4. Afshari R, Bateman DN. ECG abnormalities in co-proxamol (paracetamol/dextropropoxyphene) poisoning. J Toxicol Clin Toxicol (in press).
5. Whittington RM. Dextropropoxyphene deaths: coroner's report. Hum Toxicol 1984; 3(suppl):S175–S185.